MBX Microbix Biosystems

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity
EN
13/10/2020

Underlying

MBXMicrobix Biosystems

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Microbix Biosystems

 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Attending & Presenting at Asia Pacific POC 2025

Microbix Attending & Presenting at Asia Pacific POC 2025 Showcasing Global Utility of its QAPs at Point-of-Care Testing Conference MISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is attending and presenting at the 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases, taking place in Bangkok, Thailand from 19 to 21 June, 2025 (“POC 2025”). At POC 2025, Microbix will be presenting a poster of results about the global utility...

June 17, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Reports Results for Q2 Fiscal 2025

Microbix Reports Results for Q2 Fiscal 2025 Revenues of $5.3 million, Improved Gross Margin, and Positive Net Income MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2025 ended March 31, 2025 (“Q2” and “H1”). Sales for Q2 and H1 reflected differential growth between Antigens (up) and QAPs™ (down), alongside a markedly-improved gross margin. Management DiscussionResults for H1 were largely satisfactory,...

May 15, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix & Aurevia Introduce Novel EQA Scheme

Microbix & Aurevia Introduce Novel EQA Scheme Pilot Program for Qualifying Clinical Labs to Diagnose Bacterial Vaginosis MISSISSAUGA, Ontario and HELSINKI, Finland, May 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and Aurevia Oy via its Labquality EQAS affiliate (Aurevia), announce a pilot external quality assessment (“EQA”) program to help clinical laboratories establish their proficiency at using molecular diagnostic methods (e.g., PCR tests) to diagnose bacterial vaginosis (“BV”). ...

May 13, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Schedules Release of Results for Q2 Fiscal 2025

Microbix Schedules Release of Results for Q2 Fiscal 2025 Results Release and Webinar Discussion on Morning of May 15, 2025 MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its second quarter of fiscal 2025 ended March 31, 2025 (“Q2 2025”) prior to the start of trading on May 15, 2025. At 11:00 AM ET on that day, Microbix intends to hold a webi...

May 8, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix’s Clot-Buster Drug Project Advances

Microbix’s Clot-Buster Drug Project Advances Sequel Pharma Executes Agreement with CDMO for Drug Product Manufacturing MISSISSAUGA, Ontario, May 05, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed an agreement with a leading international contract development and manufacturing organization (“CDMO”) for production of the formulated and packaged drug (i.e., “Drug Product”) of Kinlytic® urokinase ...

May 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch